Catalyst Wire Dossier Catalyst Wire Dossier

netarsudil ophthalmic solution

netarsudil · Aerie Pharmaceuticals
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for netarsudil ophthalmic solution, covering 2016-09-13 to 2022-09-01. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy [Phase 2]

See pricing